Thyrocare Technologies Limited (BOM:539871)
403.30
+1.70 (0.42%)
At close: Feb 13, 2026
Thyrocare Technologies Revenue
Thyrocare Technologies had revenue of 1.96B INR in the quarter ending December 31, 2025, with 17.85% growth. This brings the company's revenue in the last twelve months to 7.92B, up 21.06% year-over-year. In the fiscal year ending March 31, 2025, Thyrocare Technologies had annual revenue of 6.87B with 20.19% growth.
Revenue (ttm)
7.92B
Revenue Growth
+21.06%
P/S Ratio
8.10
Revenue / Employee
4.35M
Employees
1,822
Market Cap
64.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.87B | 1.15B | 20.19% |
| Mar 31, 2024 | 5.72B | 452.20M | 8.59% |
| Mar 31, 2023 | 5.27B | -621.90M | -10.56% |
| Mar 31, 2022 | 5.89B | 942.40M | 19.05% |
| Mar 31, 2021 | 4.95B | 603.60M | 13.90% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| One Global Service Provider | 3.37B |
| Chandan Healthcare | 2.57B |
| Star Imaging and Path Lab | 860.99M |
| Modern Diagnostic & Research Centre | 814.48M |
| Invicta Diagnostic | 301.81M |
| Nidan Laboratories and Healthcare | 271.16M |
| Aspira Pathlab & Diagnostics | 242.36M |
| Clinitech Laboratory | 92.39M |
Thyrocare Technologies News
- 16 days ago - Thyrocare Technologies shares fall sharply over 4% today despite strong Q3 FY26 results - Business Upturn
- 17 days ago - Thyrocare Technologies Ltd (BOM:539871) Q3 2026 Earnings Call Highlights: Robust Revenue Growth ... - GuruFocus
- 17 days ago - Q3 2026 Thyrocare Technologies Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Thyrocare shares jump over 11% after strong Q2 results; Approves bonus issue in 2:1 ratio - Business Upturn
- 4 months ago - Thyrocare Technologies Ltd (BOM:539871) Q2 2026 Earnings Call Highlights: Strong Revenue Growth ... - GuruFocus
- 4 months ago - Q2 2026 Thyrocare Technologies Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Thyrocare Technologies Q2 Results: Revenue soars 22% YoY to Rs 216.5 crore, net profit up 79% - Business Upturn
- 7 months ago - Thyrocare shares rally over 7% as Q1 net profit rises 62% YoY Rs 38.06 crore, revenue up 23% YoY - Business Upturn